Sotevtamab, a novel bispecific agent, is generating significant interest within the oncology community, particularly regarding the potential for treating blood malignancies . This therapy functions by https://lewyseyac573059.blog-gold.com/58812211/sotevtamab-a-new-treatment-in-hematologic-malignancies